±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 1089  |  »Ø¸´: 4

Èü¿ÆÒ×Ò½Ò©

гæ (³õÈëÎÄ̳)

[½»Á÷] ÁÙ´²Ñо¿¼à²éÔ±/CRA/SCRAclinical research associate

¾ßÌ幤×÷µØµã:
±±¾©
н½ð:
ÃæÒé
ѧÀúºÍÑо¿·½Ïò:
Ò½Ò©Ñз¢
ÕÐÆ¸¸Úλ:
ÁÙ´²¼à²éÔ±
¹«Ë¾Ãû³Æ:
±±¾©Èü¿ÆÒ×Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾
¹«Ë¾ÍøÖ·:
www.sqe-pharma.com
ÁªÏµ·½Ê½:
010-63103427

¹¤×÷Ö°Ôð
1£¬°´ÕÕ·½°¸¡¢GCPºÍSOP£¬Æô¶¯¡¢¼à²éºÍ¹Ø±ÕÁÙ´²ÊÔÑ飻
2£¬¹ÜÀíÑо¿ÖÐÐÄ£»
3£¬ºÍÑо¿ÖÐÐı£³ÖÁ¼ºÃÓÐЧµÄ¹µÍ¨£»
4£¬¼°Ê±ÕýÈ·µØ±¨¸æËùÓв»Á¼Ê¼þ£»
5£¬×éÖ¯ÕÙ¿ªÁÙ´²ÊÔÑé»áÒ飻
6£¬ÅàѵÑо¿ÖÐÐÄÈËÔ±£»

ְλҪÇó£º
1£¬Ò½Ò©Ïà¹Ø×¨Òµ±¾¿Æ¼°ÒÔÉÏ£»
2£¬ÖÁÉÙ1ÄêÁÙ´²ÊÔÑéÏà¹Ø¾­Ñ飻
3£¬Á¼ºÃµÄÓ¢ÓïºÍ¼ÆËã»úˮƽ£»
4£¬Á¼ºÃµÄ¹µÍ¨ÄÜÁ¦ºÍÎÊÌâ´¦ÀíÄÜÁ¦£»
5£¬Á¼ºÃµÄÍŶӺÏ×÷¾«Éñ£»
Responsibility:
-To initiate, monitor and close clinical trials in compliance with study protocol, GCP & SOPs.
-To help managing & resolving study related issues at sites.
-To develop and maintain good and effective communication with clinical research staff.
-To report all Adverse Events timely and properly.
-To organize investigator meetings.
-To provide on-site training.

Qualification:
-Medical or Pharmacological BS,or higher degree.
-At least 1 year relevant working experience.
-Skilled at English & computer.
-Good communication and analytical skill.
-Team player.
ÓÐÒâÕßÇ뽫¼òÀú·¢Ë͵½ÓÊÏ䣺hr@sqe-pharma.com
ÁªÏµÈË£ºÎâŮʿ

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

°ÍÀ²À²

гæ (СÓÐÃûÆø)

¶¥Ò»Ï£¬Ó¦½ìÉú¿¼ÂÇÂð
2Â¥2012-05-24 14:46:41
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Èü¿ÆÒ×Ò½Ò©

гæ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by °ÍÀ²À² at 2012-05-24 14:46:41:
¶¥Ò»Ï£¬Ó¦½ìÉú¿¼ÂÇÂð

¿ÉÏÈ·¢¼òÀú¿´Ò»ÏÂ
3Â¥2012-05-24 15:42:54
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hongfeng667

ľ³æ (ÕýʽдÊÖ)

±¾¿Æ£¬ÈýÄêÑз¢¾­Ñ飬ÓÐGCPÅàѵ֤Ê飬ûCRA¾­Ñ飬ÐÐÂð
4Â¥2012-06-08 15:55:54
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÕÅѧÓñ

½ð³æ (СÓÐÃûÆø)

ûÓÐÁÙ´²ÊµÑé¾­Ñé¿ÉÒÔ·Å¿íµãÂð£¿
5Â¥2012-06-13 14:52:56
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ Èü¿ÆÒ×Ò½Ò© µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856 | GPA 4.07 | ÓпÆÑо­Àú +8 cccchenso 2026-03-29 8/400 2026-03-29 23:53 by ÎÒÊÇС¿µ
[¿¼ÑÐ] 0703 »¯Ñ§ Çóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧ 342 ·Ö +5 Shern¡ª- 2026-03-28 5/250 2026-03-29 23:32 by ·ÉÐÐÈÕ¼ÇÎ÷
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¹¤Òµ´óѧ£¬324·ÖÇóµ÷¼Á +6 Áã°Ë# 2026-03-28 6/300 2026-03-29 21:20 by nanaliuyun
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +17 µ¾ÆÞС±à 2026-03-26 17/850 2026-03-29 19:07 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +5 hanamiko 2026-03-29 5/250 2026-03-29 16:46 by ѧԱ8dgXkO
[¿¼ÑÐ] 334·Ö Ò»Ö¾Ô¸ÎäÀí ²ÄÁÏÇóµ÷¼Á +7 ÀîÀî²»·þÊä 2026-03-26 7/350 2026-03-29 16:25 by ѧԱ8dgXkO
[¿¼ÑÐ] 298Çóµ÷¼Á +3 ÖÖÊ¥´Í 2026-03-29 3/150 2026-03-29 12:06 by longlotian
[¿¼ÑÐ] 0856²ÄÁÏ»¯¹¤µ÷¼Á ×Ü·Ö330 +14 zhubinhao 2026-03-27 14/700 2026-03-29 10:01 by Sjndkwm
[¿¼ÑÐ] 356Çóµ÷¼Á +3 gysy?s?a 2026-03-28 3/150 2026-03-29 00:33 by 544594351
[¿¼ÑÐ] 295Çóµ÷¼Á +4 wei-5 2026-03-26 4/200 2026-03-28 23:20 by Сľ³ætim
[¿¼ÑÐ] 085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á +12 ·³ÕСç÷ 2026-03-27 12/600 2026-03-28 15:41 by L135790
[¿¼ÑÐ] 320·Ö£¬²ÄÁÏÓ뻯¹¤×¨Òµ£¬Çóµ÷¼Á +9 Ò»¶¨Éϰ¶aaa 2026-03-27 13/650 2026-03-28 15:00 by ÉñÂí¶¼²»¶®
[¿¼ÑÐ] 394Çóµ÷¼Á +3 ºÃʶàÄ¥¾²ºò¼ÑÒ 2026-03-26 5/250 2026-03-28 14:24 by ÌÆãå¶ù
[¿¼ÑÐ] Ò»Ö¾Ô¸ÏÃÃÅ´óѧ»¯Ñ§Ñ§Ë¶307Çóµ÷¼Á +10 y7czhao 2026-03-26 10/500 2026-03-28 14:23 by ÌÆãå¶ù
[¿¼ÑÐ] 347Çóµ÷¼Á +3 ɽ¶¥¼û¦Á 2026-03-25 3/150 2026-03-28 14:13 by ÌÆãå¶ù
[¿¼ÑÐ] 299Çóµ÷¼Á +7 àÅàÅàÅàÅ2 2026-03-27 7/350 2026-03-28 13:09 by ÌÆãå¶ù
[˶²©¼ÒÔ°] ±±¾©ÁÖÒµ´óѧ˶µ¼ÕÐÉú¹ã¸æ +6 kongweilin 2026-03-26 8/400 2026-03-27 10:18 by FF_16
[¿¼ÑÐ] 325Çóµ÷¼Á +3 Aoyijiang 2026-03-23 3/150 2026-03-26 20:46 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 0703»¯Ñ§Çóµ÷¼Á +3 µ¤ÇàÄÌ¸Ç 2026-03-26 5/250 2026-03-26 20:11 by macy2011
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì 317Çóµ÷¼Á +4 JKSOIID 2026-03-26 4/200 2026-03-26 15:58 by ²»³Ôô~µÄ؈
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û